Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
32 studies found for:    " February 20, 2008":" March 21, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Unknown  HIV-HBV Co-Infection and Liver Disease
Conditions: HIV Infections;   HIV-HBV Co-Infection
22 Completed
Has Results
Exercise and Pioglitazone for HIV-Metabolic Syndromes
Conditions: HIV Infections;   Type 2 Diabetes;   Obesity;   HIV;   AIDS;   Cardiovascular Disease;   Lipodystrophy
Interventions: Drug: Pioglitazone;   Behavioral: Exercise training
23 Unknown  Impact of Antiretroviral Therapy on Cardiac Biomarkers
Condition: HIV Infections
24 Completed Phase 2B Dose-Ranging Study of PAC113 Mouthrinse in HIV Seropositive Individuals With Oral Candidiasis
Condition: Oral Candidiasis
Intervention: Drug: PAC113
25 Completed
Has Results
The Effect of Raltegravir on HIV Decay During Primary and Chronic Infection
Condition: HIV Infection
Intervention: Drug: Tenofovir + emtricitabine + raltegravir.
26 Completed Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow
Conditions: Allergic Rhinitis;   Asthma;   Back Pain;   Benign Prostatic Hypertrophy;   Bursitis;   Depression;   Anxiety;   Diabetes Mellitus;   Esophageal Reflux;   HIV Infections;   Hyperlipidemia;   Hypertension;   Insomnia;   Irritable Bowel Syndrome;   Obesity;   Osteoporosis (Senile);   Shoulder Pain;   Sinusitis;   Symptomatic Menopause;   Urinary Incontinence;   Urinary Tract Infection;   Vaginitis
Intervention: Other: Health Information Prescription
27 Completed Raltegravir vs. Lopinavir/Ritonavir, Both in Combination With Truvada, in HIV+ Treatment Naive Individuals
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: Lopinavir/Ritonavir
28 Completed Intestinal Protozoal Infections and Sexual Transmitted Diseases Among Targeted Cohorts
Conditions: HIV Infections;   Protozoan Infections
Intervention: Genetic: amoeba
29 Completed Lopinavir/Ritonavir Monotherapy in Children
Condition: HIV Infections
Intervention: Drug: LPV/r
30 Completed Effects Of Food And Dose Regimen On The Antiviral Effects Of Maraviroc (UK-427,857) In Patients With Human Immunodeficiency Virus
Condition: HIV
Interventions: Drug: Maraviroc (UK-427,857);   Other: Placebo
31 Withdrawn Corticosteroids Therapy and Pneumocystis Jirovecii Pneumonia (PCP)
Condition: Pneumocystis Carinii Pneumonia
Interventions: Drug: Antibiotics only;   Drug: Antibiotics + Corticosteroids;   Drug: Corticosteroids + antibiotics
32 Active, not recruiting Carmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma
Condition: Lymphoma
Interventions: Drug: carmustine;   Drug: cyclophosphamide;   Drug: etoposide;   Other: pharmacological study;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: peripheral blood stem cell transplantation

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-32) Next Page   
Indicates status has not been verified in more than two years